Tort Updates & Acquisition Intel | LeadsThru Legal Platform

Sep 17, 2026 • 3 min • MDL 3094

Ozempic Gastroparesis: Bellwether Track Sets Q1 2027 Trial Date

Judicial discovery accelerates in ED Pennsylvania as severe stomach paralysis and ileus claims meet critical causation thresholds.

1. Venue Status Active MDL 3094 • ED PA

2. Retrieval Yield 92% Record Pass Rate

3. Passing Intake Criteria Severe gastroparesis + ER hospitalization + GES motility test

Sep 16, 2026 • 4 min • MDL 3065

Hair Relaxer MDL 3065: Master Docket Reaches 12,000+ Filings

Federal court advances science day findings linking endocrine-disrupting chemicals to uterine, endometrial, and ovarian carcinoma.

1. Venue Status Active MDL 3065 • ND IL

2. Retrieval Yield 88% Pathology Pass Rate

3. Passing Intake Criteria Uterine/endometrial cancer + 4+ yrs straightener usage + Biopsy

Sep 15, 2026 • 3 min • MDL 3103

Suboxone Tooth Decay: Discovery Closes Ahead Of Hearings

Lawsuits alleging failure to warn of severe dental erosion and rampant decay gain momentum following the FDA safety update.

1. Venue Status Active MDL 3103 • ND OH

2. Retrieval Yield 85% Dental Pass Rate

3. Passing Intake Criteria 2+ tooth extractions / severe decay + Sublingual film Rx records

Sep 14, 2026 • 5 min • CLJA 2022

Camp Lejeune Settlements: Navy Payouts Surpass $150M Mark

Navy JAG expands expedited settlement payouts for qualifying tier-1 illnesses including bladder, kidney, and Parkinson's claims.

1. Venue Status Active CLJA • Fast-Track Option

2. Retrieval Yield 96% Military OMPF Pass Rate

3. Passing Intake Criteria 30+ days at Lejeune (1953-1987) + Tier 1 qualifying diagnosis

Sep 12, 2026 • 3 min • Pre-MDL

Depo-Provera: BMJ Study Triggers Surge In Meningioma Claims

Landmark research confirms 5.6x increased risk of intracranial meningioma brain tumors with medroxyprogesterone use.

1. Venue Status Emerging Pre-MDL • JPML Q4

2. Retrieval Yield 91% MRI / Surgical Pass Rate

3. Passing Intake Criteria Meningioma on MRI/CT + 12+ mos Depo injections

Sep 11, 2026 • 4 min • State JCCP

Baby Food Toxics: State JCCP Courts Advance Discovery

Coordinated dockets progress against major commercial brands over dangerous heavy metal levels and developmental injuries.

1. Venue Status Emerging Coordinated JCCP

2. Retrieval Yield 82% Neuropsych Pass Rate

3. Passing Intake Criteria Diagnosed Level 2/3 Autism / severe ADHD + Verified brand usage

Sep 10, 2026 • 4 min • MDL 2873

AFFF Foam MDL 2873: Individual Cancer Bellwethers Head To Trial

Personal injury claims for firefighter kidney and testicular cancers enter active trial scheduling in Charleston.

1. Venue Status Emerging MDL 2873 • D. SC

2. Retrieval Yield 90% Exposure Log Pass Rate

3. Passing Intake Criteria Firefighting service + Diagnosed Kidney or Testicular Cancer

Sep 08, 2026 • 3 min • Class Action

Solar Financing Fraud: Class Actions Target Deceptive Liens

Surge in coordinated claims over undisclosed 25-year UCC property liens and unpermitted rooftop installations.

1. Venue Status Emerging Class Action

2. Retrieval Yield 95% Contract Pass Rate

3. Passing Intake Criteria Unconsented UCC lien + Forged electronic signatures

Sep 05, 2026 • 2 min • MDL 2885

3M Earplug Settlement: Final Intake Closes As $6B Is Distributed

Over 99% participation achieved in master settlement agreement; intake portals are officially closed for new unfiled claims.

1. Venue Status Closed • Final Administration

2. Retrieval Yield Closed for new acquisitions

3. Acquisition Recommendation Don't Fund. Existing registered claims in distribution phase only.

Sep 04, 2026 • 3 min • MDL 2738

J&J Talc Plan: Claimants Vote On Proposed $6.5B Resolution

Prepackaged Chapter 11 reorganization sets strict census cutoff dates for unfiled ovarian and mesothelioma claims.

1. Venue Status Closed • Bankruptcy Voting

2. Retrieval Yield Restricted to legacy dockets

3. Acquisition Recommendation Don't Fund without existing registered court docket number.

Sep 02, 2026 • 2 min • MDL 3014

Philips CPAP Recall: $1.1B Personal Injury Settlement Finalized

Master settlement establishes fixed compensation grids; enrollment is closed for new digital lead acquisitions.

1. Venue Status Closed • Master Settlement

2. Retrieval Yield Closed for new acquisitions

3. Acquisition Recommendation Don't Fund. Zero yield on newly generated unverified leads.

Aug 28, 2026 • 3 min • MDL 2741

Bayer RoundUp: Diminishing Digital Returns As Pool Saturates

Decade-long litigation faces high CAC and severe saturation across general consumer digital lead funnels.

1. Venue Status Closed • Saturated Market

2. Retrieval Yield Low yield on general leads

3. Acquisition Recommendation Don't Fund general leads. Transition capital to active dockets.

Tort Updates. Not News. Acquisition Intel.